Overview · Filed: —
ORD_59318/2024
TRANSCUTANEOUS ANALYTE SENSOR SYSTEMS AND METHODS
Procedural & sub-applicationsCase Management OrdersDusseldorf LDGeneric Order—
Parties
Claimants
- Dexcom Inc.(Dexcom Group)
Reps: Markus Grosch (Quinn Emanuel Urquhart & Sullivan LLP); Johannes Bukow (Quinn Emanuel Urquhart & Sullivan LLP); Jan Axtmann (Quinn Emanuel Urquhart & Sullivan LLP); Paul Lehmann (Quinn Emanuel Urquhart & Sullivan LLP)
Respondents
- Abbott Logistics B.V.(Abbott Group)
- Abbott Laboratories GmbH(Abbott Group)
- Abbott Laboratories(Abbott Group)
- Abbott Oy(Abbott Group)
- Abbott Scandinavia Aktiebolag(Abbott Group)
- Abbott (S.A./N.V.)(Abbott Group)
- Abbott B.V.(Abbott Group)
- Abbott France (S.A.S.)(Abbott Group)
- Abbott GmbH(Abbott Group)
- Abbott Diagnostics GmbH(Abbott Group)
- Abbott Gesellschaft m.b.H.(Abbott Group)
- Abbott Diabetes Care Inc.(Abbott Group)
- Abbott s.r.l.(Abbott Group)
Reps: Dietrich Kamlah (Taylor Wessing); Christian Lederer (Taylor Wessing); Gisbert Hohagen (Taylor Wessing)
Judges
- ThomasPresiding Judge / Judge-Rapporteur
- ThomLegally Qualified Judge
- RinkinenLegally Qualified Judge
Patents
- EP 4 026 488
CPC codes: A61B5/6849, A61B2560/063, A61B5/14865, A61B5/688, A61B5/14532, A61B5/14546, A61B5/6848, A61B5/6832, A61B5/68335, A61B2562/222, A61B2562/227, A61B2560/045…
Sector: Pharmaceutical & Medical
Outcome
Procedural only
Filed: —
First decided: Nov 21, 2024
Language: —